Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - paclitaxel, quantity: 6 mg/ml - injection, solution - excipient ingredients: ethanol absolute; peg-35 castor oil; citric acid - paclitaxel agila is indicated for: primary treatment of ovarian cancer in combination with a platinum agent; treatment of metastatic carcinoma of the ovary and of the breast after failure of standard therapy; adjuvant treatment of node positive breast cancer administered sequentially to doxorubicin and cyclophosphamide; treatment of metastatic cancer of the breast, in combination with trastuzumab (herceptin), in patients who have tumours that over-express her-2 and who have not received previous chemotherapy for their metatastic disease; treatment of non-small cell lung cancer (nsclc); in combination with gemcitabine (gemzar), is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/ neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated.

Ireland - English - HPRA (Health Products Regulatory Authority)

generics (uk) limited - teicoplanin - pdr for soln inj/inf - 100 milligram - teicoplanin

Ireland - English - HPRA (Health Products Regulatory Authority)

generics (uk) limited - teicoplanin - pdr for soln inj/inf - 200 milligram - teicoplanin

Ireland - English - HPRA (Health Products Regulatory Authority)

generics (uk) limited - teicoplanin - pdr for soln inj/inf - 400 milligram - teicoplanin

Singapore - English - HSA (Health Sciences Authority)

draeger singapore pte ltd - general hospital - the agila ceiling supply unit is used in rooms serving medical purposes. it provides location for equipment used in diagnostics, therapy, or for surgery, simple positioning of devices in the room in up to three dimensions, passing through media such as medical gases, vacuum, electricity, data (such as telephone, nurse call, pc networks).

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - aciclovir sodium dihydrate, quantity: 628.8 mg (equivalent: aciclovir, qty 500 mg) - injection, powder for - excipient ingredients: - aciclovir agila (aciclovir sodium) is indicated for:,- promoting resolution of acute clinical manifestations of mucocutaneous herpes simplex virus infections in immunocompromised patients,- treatment of severe first episode primary or non-primary genital herpes in immune competent patients,- treatment of acute manifestations of varicella zoster virus infection in immunocompromised patients,- treatment of herpes zoster (shingles) in immune competent patients who show very severe acute local or systemic manifestations of the disease. (benefits can be expected in patients with rash duration shorter than 72 hours. the use of the intravenous infusion may be warranted in only a small subgroup of immune competent patients with shingles).,- treatment of herpes simplex encephalitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - aciclovir sodium dihydrate, quantity: 314.4 mg (equivalent: aciclovir, qty 250 mg) - injection, powder for - excipient ingredients: - aciclovir agila (aciclovir sodium) is indicated for:,- promoting resolution of acute clinical manifestations of mucocutaneous herpes simplex virus infections in immunocompromised patients,- treatment of severe first episode primary or non-primary genital herpes in immune competent patients,- treatment of acute manifestations of varicella zoster virus infection in immunocompromised patients,- treatment of herpes zoster (shingles) in immune competent patients who show very severe acute local or systemic manifestations of the disease. (benefits can be expected in patients with rash duration shorter than 72 hours. the use of the intravenous infusion may be warranted in only a small subgroup of immune competent patients with shingles).,- treatment of herpes simplex encephalitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

medtas pty ltd - ganciclovir, quantity: 500 mg - injection, powder for - excipient ingredients: sodium hydroxide - ganciclovir agila (ganciclovir) administered as the iv infusion is indicated for the palliative treatment of confirmed sight-threatening cytomegalovirus (cmv) disease in aids and other severely immunocompromised individuals. it is indicated for the treatment of confirmed cmv pneumonitis in bone marrow transplant patients. it is also indicated for the prophylaxis of cmv infection and disease following bone marrow and solid organ transplantation in patients at risk of cmv disease.,note: ganciclovir agila (ganciclovir) is not indicated for congenital or neonatal cmv disease; nor for the treatment of cmv infection in non-immunocompromised individuals.

Singapore - English - HSA (Health Sciences Authority)

good pharmaceutical pte. ltd. - hydrocortisone sodium succinate 133.67mg equivalent to hydrocortisone - injection, powder, lyophilized, for solution - 100mg

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - vancomycin hydrochloride 512.571mg equivalent to vancomycin - injection, powder, for solution - 500mg